Roche has forked out $220 million to acquire Constitution Medical Investors (CMI). The Boston, Massachusetts company is the developer of BloodHound, an automated hematology testing system for faster and more accurate diagnosis of blood-related diseases.
Read the full article – start your free trial today!
Join thousands of industry professionals who rely on Medtech Insight for daily insights
- Start your 7-day free trial
- Explore trusted news, analysis, and insights
- Access comprehensive global coverage
- Enjoy instant access – no credit card required
Already a subscriber?